Raymond James Financial’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.06M Buy
497,414
+272,495
+121% +$4.07M ﹤0.01% 2930
2026
Q2
$5.36M Buy
224,919
+75,881
+51% +$1.46M ﹤0.01% 2679
2026
Q1
$2.63M Buy
149,038
+47,750
+47% +$959K ﹤0.01% 3136
2025
Q4
$2M Sell
101,288
-16,347
-14% -$294K ﹤0.01% 3275
2025
Q3
$2.05M Sell
117,635
-19,654
-14% -$291K ﹤0.01% 3153
2025
Q2
$1.92M Sell
137,289
-68,885
-33% -$1.11M ﹤0.01% 3111
2025
Q1
$3.84M Buy
206,174
+48,901
+31% +$729K ﹤0.01% 2504
2024
Q4
$1.77M Buy
+157,273
New +$1.84M ﹤0.01% 3056

Other funds holding ALHC

Raymond James Financial's ALHC Position: Q3 2026 in Review

Raymond James Financial increased its Alignment Healthcare (ALHC) stake by 121% in Q3 2026, buying an estimated $4.07M and bringing the position to 497,414 shares worth $4.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2930.

Raymond James Financial first reported a position in ALHC in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.36M in Q2 2026. 323 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • Raymond James Financial held 497,414 shares of Alignment Healthcare worth $4.06M as of Q3 2026.
  • Raymond James Financial bought 272,495 Alignment Healthcare shares in Q3 2026, an estimated $4.07M.
  • Alignment Healthcare made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2930 holding.
  • Raymond James Financial first reported a position in Alignment Healthcare in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Alignment Healthcare position peaked at $5.36M in Q2 2026.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.